Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-h)-dione, 21-acetate
2. Aemcolo
3. Otafa
4. R-75-1
5. Rifacin
6. Rifamicina Colirio
7. Rifamycin Sv
8. Rifamycin Sv, Monosodium Salt
9. Rifamycin Sv, Sodium Salt
10. Rifamycine Chibret
11. Rifocina
12. Rifocyna
1. Rifamycin Sv Sodium
2. Rifamycin Sv Sodium Salt
3. Rifamastene
4. 14897-39-3
5. Rifamycin Sodium [usan]
6. Rifamycin Sv Monosodium Salt
7. Aemcolo
8. Monosodium Rifamycin Sv
9. 32086gs35z
10. Rifamycin, Monosodium Salt
11. Dsstox_cid_20208
12. Dsstox_rid_79452
13. Dsstox_gsid_40208
14. Sodium;(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate
15. Sodium Rifomycin Sv
16. Cas-14897-39-3
17. Cb-0111
18. Nsc 133100
19. Rifamycinsodium
20. Rifamyzin-natrium
21. Rifamycinum Natricum
22. Rifamycin, Sodium Salt
23. Mfcd09752825
24. Cb-01-11, Rifamycin Sv
25. Dtxsid0040208
26. Unii-32086gs35z
27. Rifamycin Sodium [mart.]
28. Rifamycin Sodium [who-dd]
29. Einecs 238-965-7
30. Tox21_112064
31. Tox21_202806
32. Rifamycin Sodium [ep Impurity]
33. Rifamycin Sodium [orange Book]
34. Rifamycin Sv Sodium Salt [mi]
35. Rifamycin Sodium [ep Monograph]
36. Ncgc00260352-01
37. 2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2h)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, Monosodium Salt
38. 2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2h)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, Sodium
39. J-008536
40. Q27256110
41. Rifamycin Sv Sodium Salt, Potency: >=900 Units (dry Basis)
42. 2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2h)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, Sodium Salt
43. Sodium (2s,12z,14e,16s,17s,18r,19r,20r,21s,22r,23s,24e)-21-(acetyloxy)- 6,9,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2- Dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-5-olate
Molecular Weight | 719.7 g/mol |
---|---|
Molecular Formula | C37H46NNaO12 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 3 |
Exact Mass | 719.29177018 g/mol |
Monoisotopic Mass | 719.29177018 g/mol |
Topological Polar Surface Area | 204 Ų |
Heavy Atom Count | 51 |
Formal Charge | 0 |
Complexity | 1340 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antirheumatic Agents
Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)
Certificate Number : R1-CEP 2011-233 - Rev 03
Issue Date : 2021-12-17
Type : Chemical
Substance Number : 432
Status : Valid
Available Reg Filing : ROW |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2000-336 - Rev 03
Issue Date : 2005-02-18
Type : TSE
Substance Number : 432
Status : Withdrawn by Holder
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23616
Submission : 2010-03-08
Status : Active
Type : II
Certificate Number : R1-CEP 2010-035 - Rev 01
Issue Date : 2016-11-04
Type : Chemical
Substance Number : 432
Status : Valid
NDC Package Code : 52972-0036
Start Marketing Date : 2010-04-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35706
Submission : 2021-11-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22907
Submission : 2009-06-24
Status : Active
Type : II
Certificate Number : CEP 2021-490 - Rev 00
Issue Date : 2024-05-16
Type : Chemical
Substance Number : 432
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23616
Submission : 2010-03-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35706
Submission : 2021-11-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22907
Submission : 2009-06-24
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?